---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-008332"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2024-11-21T23:59:59+00:00"
generated_at: "2026-05-29T20:28:38.033478+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals terminates exclusive supply agreement with EMC Pharma

## Summary
- EMC Pharma failed to meet minimum purchase quantities; 30-day cure period expired.
- Termination effective November 21, 2024; no penalties incurred by Sonoma.
- Sonoma resumes direct U.S. sales of Microcyn-based products: Acuicyn, Celacyn, Epicyn, Lasercyn, Levicyn.
- Agreement had a five-year initial term; exclusive distribution rights now ended.

## SEC filing metadata
- accession: 0001683168-24-008332
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2024-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316824008332/0001683168-24-008332-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316824008332/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-008332
- JSON: https://secwatch.observer/filing/0001683168-24-008332.json
- Plain text: https://secwatch.observer/filing/0001683168-24-008332.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.